Latest Shareholder Impact News

Nova Minerals has signed a Scheme Implementation Deed to redomicile to the US, aiming for a primary NYSE listing while retaining a secondary ASX listing via CDIs. The move seeks to align corporate structure with its Alaskan operations and enhance access to US capital markets.

Codeifai Limited reported a 26% revenue decline to $598,497 for 2025 alongside a sharp increase in net loss to $6.22 million, driven by strategic investments and market challenges. The company’s pivot to self-service SaaS platforms, including a key acquisition post-year-end, signals a transformative but uncertain path forward.

Appen Limited has reported a slight revenue decline and a notable increase in net loss for the 2025 financial year, prompting the company to withhold its final dividend.

Recharge Metals Limited has launched a pro-rata entitlement issue to raise $2.06 million, alongside a $3.97 million placement and a strategic acquisition of the Sunset Well Project in Western Australia. The capital raising aims to fund exploration and working capital, but shareholders face significant dilution and funding risks.

Identitii Limited has reopened its pro rata rights issue following a Takeovers Panel ruling, granting shareholders withdrawal rights and terminating the underwriting agreement.

Marimaca Copper has successfully raised C$409 million through a dual Canadian and Australian equity offering, positioning the company to advance its flagship Marimaca Project and exploration at Pampa Medina.

BKI Investment Company has finalised its on-market share purchases to satisfy its Dividend Reinvestment Plan obligations, setting the DRP price at $1.74 ahead of the 2026 interim dividend payment.

Regal Asian Investments Limited (ASX, RG8) has updated its Dividend Reinvestment Plan, eliminating the minimum participation requirement and streamlining administrative processes for shareholders.

Verity Resources Limited has announced a pro-rata entitlement issue to raise up to $2.05 million, partially underwritten by entities linked to its directors. The capital raise aims to fund exploration and technical studies across its key projects, including the Monument Gold Project.

Neuren Pharmaceuticals has initiated a discretionary on-market share buy-back program of up to 5%, citing a strong cash position and undervaluation relative to internal and analyst assessments.

BKI Investment Company has appointed Morgans Financial to conduct on-market share purchases to fulfill its Dividend Reinvestment Plan obligations, aiming to avoid dilution by pricing shares at no discount.

Cosmo Metals Limited has announced a fully underwritten entitlement offer to raise approximately $1.55 million, aimed at advancing drilling and exploration across its key gold and base metals projects. The offer includes new shares and attaching options, with funds earmarked for multiple projects in Western Australia and New South Wales.